New England Biolabs®, Inc., Announces the NEBNext® Immune Sequencing Kits (Human and Mouse) for Sequencing-based Profiling of T- and B-Cell-mediated Immune Responses
Retrieved on:
Thursday, August 19, 2021
Yale University, George Washington University School of Engineering and Applied Science, Associate, Polymerase chain reaction, Immunoglobulin M, Blood, PCR, NEB, Severe acute respiratory syndrome coronavirus 2, BCR, Washington University School of Medicine, Infection, Unique molecular identifier, Research, Immunoglobulin A, Consensus sequence, Lymph, Cell, Somatic mutation, Mouse, Degenerative disease, UMI, RNA transfection, Immunoglobulin E, Immunoglobulin G, Solution, Bias, Publication, Immunoglobulin D, III, NGS, New England Biolabs, Autoimmunity, Rituximab, COVID-19, TCR, Vaccine, Animal
The kits' streamlined workflows and flexibility make them particularly useful for studies investigating the human immune response to infection and autoimmunity.
Key Points:
- The kits' streamlined workflows and flexibility make them particularly useful for studies investigating the human immune response to infection and autoimmunity.
- The NEBNext Immune Sequencing Kits directly serve the translational research market and include a bioinformatic workflow on the Galaxy platform, based on the open-source pRESTO toolkit.
- Several publications from his lab demonstrated the use of the NEBNext Immune Sequencing Kit (Human) for these translational research studies.
- The full product description and ordering details for the NEBNext Immune Sequencing Kit (Human) and NEBNext Immune Sequencing Kit (Mouse) can be found at www.neb.com/E6320 and www.neb.com/E6330 respectively.